Hangzhou Tigermed Consulting Co., Ltd (SHE: 300347)

Hangzhou Tigermed Consulting Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 18, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	48,683	44,807	87,567	104,196	139,718	47,335
Market Cap Growth	2.16%	-48.83%	-15.96%	-25.42%	195.17%	121.37%
Enterprise Value	54,144	44,345	85,466	98,831	130,576	47,065
Last Close Price	60.90	54.33	102.69	124.47	157.13	61.19
PE Ratio	54.96	22.13	43.64	36.25	79.85	56.24
Forward PE	31.54	19.90	32.89	48.60	111.97	51.37
PS Ratio	7.74	6.07	12.36	19.99	43.77	16.89
PB Ratio	2.51	1.83	3.86	5.06	7.82	8.57
P/TBV Ratio	3.09	2.50	5.22	6.47	9.61	15.93
P/FCF Ratio	77.40	53.55	96.34	98.75	165.90	111.47
P/OCF Ratio	52.42	38.95	64.51	73.18	139.90	89.72
EV/Sales Ratio	7.96	6.01	12.06	18.96	40.90	16.79
EV/EBITDA Ratio	32.53	23.64	44.48	67.76	136.22	62.22
EV/EBIT Ratio	40.44	26.23	48.48	73.55	148.61	65.99
EV/FCF Ratio	79.89	53.00	94.03	93.66	155.05	110.83
Debt / Equity Ratio	0.17	0.14	0.12	0.05	0.02	0.18
Debt / EBITDA Ratio	2.49	1.68	1.34	0.64	0.32	1.35
Debt / FCF Ratio	6.13	4.00	2.99	0.92	0.39	2.40
Asset Turnover	0.23	0.26	0.28	0.24	0.24	0.47
Inventory Turnover	172.55	199.06	302.27	544.16	566.25	1740.11
Quick Ratio	1.32	2.72	2.95	4.46	10.17	1.86
Current Ratio	1.37	2.74	2.98	4.50	10.22	1.88
Return on Equity (ROE)	4.19%	9.12%	10.50%	17.64%	17.36%	22.80%
Return on Assets (ROA)	2.77%	3.70%	4.30%	3.88%	4.06%	7.55%
Return on Capital (ROIC)	2.96%	3.97%	4.69%	4.22%	4.44%	8.76%
Earnings Yield	1.82%	4.52%	2.29%	2.76%	1.25%	1.78%
FCF Yield	1.29%	1.87%	1.04%	1.01%	0.60%	0.90%
Dividend Yield	0.93%	1.05%	0.54%	0.40%	0.19%	0.45%
Payout Ratio	65.49%	29.13%	24.52%	9.89%	15.50%	31.60%
Buyback Yield / Dilution	0.44%	0.07%	0.62%	-9.01%	-7.27%	0.63%
Total Shareholder Return	1.37%	1.11%	1.16%	-8.61%	-7.08%	1.08%

Source: S&P Capital IQ. Standard template. Financial Sources.